Influence of Electronic Cigarettes in the Evaluation of the Inflammatory Response in Patients With a Diagnosis of COPD

NCT02892396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2020-02-06

No results posted yet for this study

Summary

This study evaluates the local and systemic inflammatory response in the airway in COPD patients who consume electronic cigarettes compared with conventional cigarette smokers.

Conditions

Sponsors & Collaborators

  • Fundacio Catalana de Pneumologia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2018-08-31
Completion
2019-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02892396 on ClinicalTrials.gov